Substituted piperidine compound and use thereof
US-2019031611-A1 · Jan 31, 2019 · US
Substituted piperidine compound and use thereof
US10898737B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10898737-B2 |
| Application number | US-201916410463-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 13, 2019 |
| Priority date | Feb 4, 2016 |
| Publication date | Jan 26, 2021 |
| Grant date | Jan 26, 2021 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Provided is a substituted piperidine compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as a prophylactic or therapeutic agent for narcolepsy.
First claim
Opening claim text (preview).
The invention claimed is: 1. A pharmaceutical composition comprising methyl (2R,3S)-3-((methyl sulfonyl)amino)-2-(((cis-4-phenylcyclohexyl)oxy)methyl)piperidine-1-carboxylate or a salt thereof.
Assignees
Inventors
Classifications
Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals · CPC title
Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates · CPC title
Oxygen atoms · CPC title
Halogen atoms or nitro radicals · CPC title
- C07F7/1804Primary
Compounds having Si-O-C linkages (Si-O-acyl linkages C07F7/1896) · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10898737B2 cover?
- Provided is a substituted piperidine compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as a prophylactic or therapeutic agent for narcolepsy.
- Who is the assignee on this patent?
- Takeda Pharmaceuticals Co
- What technology area does this patent fall under?
- Primary CPC classification C07F7/1804. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Jan 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).